1. Home
  2. PVLA vs JBSS Comparison

PVLA vs JBSS Comparison

Compare PVLA & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • JBSS
  • Stock Information
  • Founded
  • PVLA 2015
  • JBSS 1959
  • Country
  • PVLA United States
  • JBSS United States
  • Employees
  • PVLA N/A
  • JBSS N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • PVLA Health Care
  • JBSS Consumer Staples
  • Exchange
  • PVLA Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • PVLA 888.0M
  • JBSS 747.8M
  • IPO Year
  • PVLA N/A
  • JBSS 1991
  • Fundamental
  • Price
  • PVLA $81.40
  • JBSS $67.77
  • Analyst Decision
  • PVLA Strong Buy
  • JBSS Strong Buy
  • Analyst Count
  • PVLA 13
  • JBSS 1
  • Target Price
  • PVLA $99.38
  • JBSS $109.00
  • AVG Volume (30 Days)
  • PVLA 163.2K
  • JBSS 81.7K
  • Earning Date
  • PVLA 11-11-2025
  • JBSS 10-29-2025
  • Dividend Yield
  • PVLA N/A
  • JBSS 3.70%
  • EPS Growth
  • PVLA N/A
  • JBSS 21.12
  • EPS
  • PVLA N/A
  • JBSS 5.62
  • Revenue
  • PVLA N/A
  • JBSS $1,129,733,000.00
  • Revenue This Year
  • PVLA N/A
  • JBSS N/A
  • Revenue Next Year
  • PVLA N/A
  • JBSS N/A
  • P/E Ratio
  • PVLA N/A
  • JBSS $12.03
  • Revenue Growth
  • PVLA N/A
  • JBSS 1.88
  • 52 Week Low
  • PVLA $11.17
  • JBSS $58.47
  • 52 Week High
  • PVLA $85.30
  • JBSS $91.98
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 59.88
  • JBSS 58.87
  • Support Level
  • PVLA $78.99
  • JBSS $67.12
  • Resistance Level
  • PVLA $85.03
  • JBSS $70.13
  • Average True Range (ATR)
  • PVLA 5.58
  • JBSS 2.31
  • MACD
  • PVLA -0.02
  • JBSS 0.31
  • Stochastic Oscillator
  • PVLA 63.39
  • JBSS 80.56

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: